
Artificial Heart Valve System Developer
Source: Cailian Press
[NewMed, Dongxiao Biotech, and Other Three Companies Launch IPO Coaching] According to Cailian Press on January 9, the official website of the CSRC disclosed that Shanghai NewMed Medical Co., Ltd., Dongxiao Biotech Co., Ltd., and Shanghai Tianze Cloud Biopharmaceutical Co., Ltd. have initiated A-share listing coaching.